Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CHAMPLAIN TOXICOLOGY LAB, LLC

NPI: 1043869068 · PLATTSBURGH, NY 12901 · Clinical Medical Laboratory · NPI assigned 09/11/2019

$269K
Total Medicaid Paid
15,339
Total Claims
13,706
Beneficiaries
9
Codes Billed
2021-03
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBONNABESSE, THIERRY (OWNER / PRESIDENT)
NPI Enumeration Date09/11/2019

Related Entities

Other providers sharing the same authorized official: BONNABESSE, THIERRY

ProviderCityStateTotal Paid
ADIRONDACK INTERVENTIONAL PHYSIATRY PC PLATTSBURGH NY $1.45M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 1,532 $6K
2022 2,710 $10K
2023 4,037 $52K
2024 7,060 $202K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,974 1,632 $133K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,924 6,958 $121K
80349 1,864 1,708 $5K
80348 1,287 1,153 $3K
80365 1,082 1,068 $3K
80361 1,021 1,011 $3K
80324 158 147 $420.16
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 17 17 $82.96
80353 12 12 $18.18